Aims To assess cytokine levels in peripheral blood and tears of patients after allogeneic haematopoietic stem cell ...

Imminent launch of grant-funded clinical trial in graft-versus-host disease (GVHD)Advancing clinical program in severe pulmonary inflammatory ...

CancerBuddy connects users through shared diagnoses and experiences, offering community when hospital walls feel especially ...

The U.S. Department of Energy's National Nuclear Security Administration has removed Cesium-137 Irradiators from medical facilities across the country over concerns that they could be used to create ...

Mesoblast Limited ( ($AU:MSB) ) has provided an announcement. Mesoblast Limited announced that its allogeneic cell therapy products, manufactured ...

Ryoncil ® (remestemcel-L) is the only allogeneic mesenchymal stromal cell therapy approved by U.S. Food and Drug Administration (FDA) for any indication. As documented in the Company’s Biologic ...

Led by former founders of a biotech AstraZeneca acquired in 2023, AllRock Bio is starting out with a drug licensed from ...

Orca Bio spent the past few years building out a 100,000-square-foot facility in Metro Air Park near the Sacramento International Airport.

During a live event, Michael R. Bishop, MD, discussed a case of steroid-refractory GVHD and the efficacy and safety outcomes ...

UCLA researchers have made strides in developing a stem cell gene therapy for alpha thalassemia major, a severe, inherited ...